About Verve Therapeutics Verve Therapeutics, Inc. (Nasdaq: VERV) is a clinical-stage company developing a new class of genetic medicines for cardiovascular disease with the potential to transform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback